Clin2
NCT04715022Possibly a fitRecruiting

Vitamin C study for insulin resistance in obesity

HypertensionCardiovascular Diseases

Treatments studied

Part of Heart & circulation clinical trials.

This early-stage study tests whether vitamin C (and possibly how your body uses it) affects blood vessel function in people with obesity and insulin resistance. You may be asked to stop certain supplements before starting so researchers can measure the effect more clearly.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
23 people
Ages
35 years to 65 years
Study type
Interventional

Who can take part

  • Your body mass index (BMI) is over 30
  • You are between 35 and 65 years old
  • You can stop vitamin C and E supplements and omega-3 supplements starting 2 weeks before the study
  • You agree to sign a written informed consent form

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04832009Recruiting· Early Phase 1
Test a way to improve blood vessel function with lifestyle

This early-phase study looks at whether a treatment can help reverse problems in blood vessels caused by high glucose (sugar) and blood fat signals. It may be a fit if you are generally healthy, have normal insulin and sugar levels, and have a stable weight.

Kansas City, Kansas
NCT06320951Not yet recruiting· Phase 2
Can a drug that relaxes blood vessels help Black adults with obesity?

This study tests whether a medication that helps relax blood vessels can improve heart and metabolic health in Black adults with obesity and early signs of insulin resistance. It may help lower blood pressure and reduce risk of heart disease.

Birmingham, Alabama
NCT02646475Recruiting· Phase 1
Study angiotensin medicine to improve metabolism in obesity

This Phase 1 study tests how a medication that affects the body’s angiotensin system (angiotensin-(1-7)) changes metabolism in adults with obesity, insulin resistance, and high blood pressure. It may help researchers understand whether this approach can improve blood sugar/insulin function and related body changes.

Nashville, Tennessee
NCT07360275Not yet recruiting· Phase 2
Study of VCT220 for people with high blood pressure and obesity

This trial tests an investigational drug called VCT220 in adults who have high blood pressure and are overweight or obese. The study will see if VCT220 can help lower blood pressure and support weight loss.

Beijing, Beijing Municipality
NCT06626113Recruiting
Nerve activity and obesity study

This trial looks at how the nerves that control blood pressure work in people with obesity and insulin resistance. It may help explain why some people develop high blood pressure and others don't.

Kansas City, Kansas
NCT07653464Not yet recruiting· Early Phase 1
Insulin's effects on blood vessels in obesity

This study looks at how insulin affects blood vessels and the brain in people with obesity and insulin resistance, compared to healthy-weight individuals. It may help explain why obesity raises heart and blood vessel risks.

Columbia, Missouri

Hear when a new High blood pressure trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.